Results 231 to 240 of about 1,294,431 (344)

MONOCYTIC LEUKEMIA (GENERAL REVIEW OF THE SUBJECT)

, 1942
Theodore S. Evans
openalex   +1 more source

Serum Anti-Proteases in the Leukemias [PDF]

, 1951
Philip M. West, BETTY W. SMITH
openalex   +1 more source

Nanomedicine‐Driven Modulation of Reductive Stress for Cancer Therapy

Advanced Science, EarlyView.
This article introduces a novel therapeutic paradigm that deliberately induces reductive stress within tumor cells to exploit their unique biochemical vulnerabilities. It systematically reviews the underlying biological mechanisms, current detection and monitoring techniques, and emerging advanced nanotechnology platforms specifically designed to ...
Yumin Mao, Xianping Liu, Xu Chu, Feixiang Chen, Ruicheng Shi, Zonghao Liu, Yelin Wu, Yanyan Liu, Wenbo Bu   +8 more
wiley   +1 more source

Isolated Central Nervous System Presentation of Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma: A Rare Case of Exclusive Brain Involvement. [PDF]

Case Rep Hematol
Swart VO, Zoghi B.
europepmc   +1 more source

CARBAMATES IN THE CHEMOTHERAPY OF LEUKEMIA [PDF]

, 1948
Howard E. Skipper, WILLIAM H. RISER, Anne Stelzenmuller, Helen Holt   +3 more
openalex   +1 more source

Inhibiting FAT1 Blocks Metabolic Bypass to Enhance Antitumor Efficacy of TCA Cycle Inhibition through Suppressing CPT1A‐Dependent Fatty Acid Oxidation

Advanced Science, EarlyView.
This study demonstrates that mutant FAT1 promotes ASCL2‐driven, CPT1A‐dependent fatty acid oxidation, leading to resistance to CPI‐613‐mediated TCA cycle inhibition in head and neck cancer. In vivo gene depletion of mutant FAT1 with LNP‐sgFAT1 suppresses tumor growth and restores CPI‐613 sensitivity, revealing a targetable metabolic bypass with ...
Fanghui Chen, Jianqiang Yang, David O. Popoola, Fan Yang, Yajie Liu, Dongsheng Wang, Zhaohui S. Qin, Zhengjia Chen, Nabil F. Saba, Zhuo G. Chen, Yamin Li, Yong Teng   +11 more
wiley   +1 more source

One step further in targeting acute leukemia by combining antibody-based immunotherapies and small molecule inhibitors. [PDF]

Cancer Cell Int
Dozandeh-Jouybari A, Rohaninia E, Faaliat S, Joudaki N, Ghandi S, Moghaddam MT, Taghiloo S, Kazemi T.   +7 more
europepmc   +1 more source

Etiology of Leukemia [PDF]

, 1957
A. Kirschbaum
openalex   +1 more source

Combining PIM‐2 and PARP1 Inhibitors Induces MICA Expression on Multiple Myeloma Cells to Activate NK Cells through NKG2D Binding

Advanced Science, EarlyView.
The findings suggest that the combination of PIM‐2 and PARP1 inhibitors can induce MICA expression on MM cells, thereby activating NK cells through NKG2D binding. This process may restore NK cell function and serve as a potential therapeutic approach for MM patients. Abstract While immunogenic death in tumor cells activates specific anti‐tumor T cells,
Zhaoyun Liu, Wenhui Lei, Xiaohan Liu, Hui Liu, Kai Ding, Jia Song, Rong Fu   +6 more
wiley   +1 more source

Periplocin Targets HDAC10 to Inhibit NF-κB Signaling and Induce Apoptosis in Myeloid Leukemia Cells. [PDF]

J Cancer
Li W, Lai S, Chen J, Chen Z, Zhou Y, Wei R, Chen Y.   +6 more
europepmc   +1 more source